Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 178-188

  Oldak, Monika ^a,b   Tolzmann, Liv ^c   Wnorowski, Artur ^a,b   Podgórska, Marta Justyna ^a,b   Silling, Steffi ^c   Lin, Rongtuan ^d   Hiscott, John ^d   Müller, Cornelia Sigrid Lissi ^a   Vogt, Thomas ^a   Smola, Hans ^c,e   Smola, Sigrun ^a,c  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c UNIVERSITY OF COLOGNE   (Germany)

^d MCGILL UNIVERSITY   (Canada)

^e Paul Hartmann AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 8; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION; VIRUS TRANSCRIPTION; WART VIRUS;

BETAPAPILLOMAVIRUS; CELL LINE, TUMOR; CELLS, CULTURED; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; KERATINOCYTES; TRANSCRIPTION, GENETIC;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 8; PAPILLOMAVIRIDAE;

EID: 78650043452     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00998-10     Document Type: Article

References (48)

1. Akgul, B., M. Curten, H. Haigis, I. Rogosz, and H. Pfister. 2006. Interferon regulatory factor 5.2 acts as a transcription repressor of epidermodysplasia verruciformis-associated human papillomaviruses. Arch. Virol. 151:2461-2473.
2. Akgul, B., W. Lemme, R. Garcia-Escudero, A. Storey, and H. J. Pfister. 2005. UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch. Virol. 150:145-151.
3. Reference deleted.
4. Au, W. C., and P. M. Pitha. 2001. Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters. J. Biol. Chem. 276:41629-41637.
5. Baskan, E. B., S. Tunali, S. B. Adim, A. Turan, and S. Toker. 2006. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge. J. Dermatolog. Treat. 17:179-183.
6. Beglin, M., M. Melar-New, and L. Laimins. 2009. Human papillomaviruses and the interferon response. J. Interferon Cytokine Res. 29:629-635.
7. Chen, H., J. Huang, F. Y. Wu, G. Liao, L. Hutt-Fletcher, and S. D. Hayward. 2005. Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J. Virol. 79:1724-1733.
8. Dole, V. S., H. Smola, S. Dooley, H. M. Said, M. Oldak, H. J. Pfister, and S. Smola. 2009. The adenoviral E1A oncoprotein activates the Smad7 promoter: requirement of a functional E-box. Int. J. Oncol. 35:1493-1498.
9. Fujii, Y., T. Shimizu, M. Kusumoto, Y. Kyogoku, T. Taniguchi, and T. Hakoshima. 1999. Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J. 18:5028-5041. (Pubitemid 29443805)
10. Garland, S. M., R. Waddell, A. Mindel, I. M. Denham, and J. C. McCloskey. 2006. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women. Int. J. STD AIDS 17:448-452.
11. Genin, P., M. Algarte, P. Roof, R. Lin, and J. Hiscott. 2000. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J. Immunol. 164:5352-5361.
12. Genin, P., A. Vaccaro, and A. Civas. 2009. The role of differential expression of human interferon-a genes in antiviral immunity. Cytokine Growth Factor Rev. 20:283-295.
13. Habig, M., H. Smola, V. S. Dole, R. Derynck, H. Pfister, and S. Smola-Hess. 2006. E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch. Virol. 151:1961-1972.
14. Hadaschik, D., K. Hinterkeuser, M. Oldak, H. J. Pfister, and S. Smola-Hess. 2003. The papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation. J. Virol. 77:5253-5265. (Pubitemid 36460939)
15. Hoshino, K., T. Sugiyama, M. Matsumoto, T. Tanaka, M. Saito, H. Hemmi, O. Ohara, S. Akira, and T. Kaisho. 2006. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440:949-953.
16. Hu, W., G. Nuovo, M. Willen, and S. Somach. 2004. Epidermodysplasia verruciformis in two half brothers with HIV infection. J. Cutan. Med. Surg. 8:357-360.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2007. Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 90:1-636.
18. Janssen, K., G. P. Lucker, R. H. Houwing, and R. van Rijssel. 2007. Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod. Int. J. Dermatol. 46(Suppl. 3):45-47.
19. Kalali, B. N., G. Kollisch, J. Mages, T. Muller, S. Bauer, H. Wagner, J. Ring, R. Lang, M. Mempel, and M. Ollert. 2008. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling. J. Immunol. 181:2694-2704.
20. Kim, T. K., T. Kim, T. Y. Kim, W. G. Lee, and J. Yim. 2000. Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway. Cancer Res. 60:1153-1156.
21. Koromilas, A. E., S. Li, and G. Matlashewski. 2001. Control of interferon signaling in human papillomavirus infection. Cytokine Growth Factor Rev. 12:157-170. (Pubitemid 32588142)
22. Lin, R., P. Genin, Y. Mamane, and J. Hiscott. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:6342-6353.
23. Lin, R., C. Heylbroeck, P. Genin, P. M. Pitha, and J. Hiscott. 1999. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 19:959-966.
24. Lin, R., Y. Mamane, and J. Hiscott. 2000. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275:34320-34327.
25. Lin, R., Y. Mamane, and J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19:2465-2474.
26. Marcuzzi, G. P., M. Hufbauer, H. U. Kasper, S. J. Weissenborn, S. Smola, and H. Pfister. 2009. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J. Gen. Virol. 90:2855-2864.
27. Miller, R. L., T. C. Meng, and M. A. Tomai. 2008. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect. 21:69-87.
28. Ning, S., A. M. Hahn, L. E. Huye, and J. S. Pagano. 2003. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. J. Virol. 77:9359-9368.
29. Ning, S., L. E. Huye, and J. S. Pagano. 2005. Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J. Virol. 79:11671-11676.
30. Nonkwelo, C., I. K. Ruf, and J. Sample. 1997. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. J. Virol. 71:6887-6897. (Pubitemid 27355351)
31. Oldak, M., R. B. Maksym, T. Sperling, M. Yaniv, H. Smola, H. J. Pfister, J. Malejczyk, and S. Smola. 2010. Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. J. Virol. 84:1376-1386.
32. Oldak, M., H. Smola, M. Aumailley, F. Rivero, H. Pfister, and S. Smola-Hess. 2004. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J. Virol. 78:10738-10746. (Pubitemid 39258399)
33. Park, J. S., E. J. Kim, H. J. Kwon, E. S. Hwang, S. E. Namkoong, and S. J. Um. 2000. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275:6764-6769.
34. Perea, S. E., P. Massimi, and L. Banks. 2000. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int. J. Mol. Med. 5:661-666.
35. Pfister, H. 2003. Human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 31:52-56.
36. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27:370-383.
37. Pichlmair, A., O. Schulz, C. P. Tan, T. I. Naslund, P. Liljestrom, F. Weber, and C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:997-1001.
38. Purdie, K. J., C. J. Sexton, C. M. Proby, M. T. Glover, A. T. Williams, J. N. Stables, and I. M. Leigh. 1993. Malignant transformation of cutaneous lesions in renal allograft patients: a role for human papillomavirus. Cancer Res. 53:5328-5333.
39. Quandt, K., K. Frech, H. Karas, E. Wingender, and T. Werner. 1995. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23:4878-4884. (Pubitemid 3008389)
40. Ronco, L. V., A. Y. Karpova, M. Vidal, and P. M. Howley. 1998. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:2061-2072.
41. Schaper, I. D., G. P. Marcuzzi, S. J. Weissenborn, H. U. Kasper, V. Dries, N. Smyth, P. Fuchs, and H. Pfister. 2005. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 65:1394-1400.
42. Smola-Hess, S., and H. Pfister. 2006. Immune evasion in genital papillomavirus infection and cervical cancer: role of cytokines and chemokines, p. 324-339. In M. S. Campo (ed.), Papillomavirus research from natural history to vaccines and beyond. Caister Academic Press, Norfolk, United Kingdom.
43. Smola-Hess, S., and H. J. Pfister. 2002. Interaction of papillomaviral oncoproteins with cellular factors, p. 431-450. In E. B. Andreas Holzenburg (ed.), Structure-function relationships of human pathogenic viruses. Kluwer Academic/Plenum Publishers, New York, NY.
44. Steger, G., and H. Pfister. 2007. Transcription and gene expression of epidermodysplasia-verruciformis associated human papillomavirus types, p. 183-201. In B. Norrild (ed.), Human papillomavirus gene regulation and transformation. Transworld Research Network, Kerala, India.
45. Stubenrauch, F., J. Malejczyk, P. G. Fuchs, and H. Pfister. 1992. Late promoter of human papillomavirus type 8 and its regulation. J. Virol. 66:3485-3493.
46. Takaoka, A., T. Tamura, and T. Taniguchi. 2008. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 99:467-478. (Pubitemid 351228562)
47. Terenzi, F., P. Saikia, and G. C. Sen. 2008. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J. 27:3311-3321.
48. zur Hausen, H. 2009. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 384:260-265. [Epub ahead of print 8 January 2009.]